← Return to Have you tried the new Protocol 525 product for neuropathy relief?

Discussion

Have you tried the new Protocol 525 product for neuropathy relief?

Neuropathy | Last Active: Nov 20 6:43am | Replies (299)
Comment receiving replies
@johnbishop

@sita I should have mentioned that I took the list of supplements and shared them with my primary care doctor to see if they had any problems or issues with me taking them. My primary care doctor at the time ran them by a Mayo Clinic pharmacist who said they thought the omega 3 and 6 supplement may be too much. After hearing that I had done some research on my own about therapeutic levels used for different health conditions and decided it was worth it for me.

Omega-3 Fatty Acids and Neuropathic Pain - Case studies demonstrate that oral intake of omega-3 polyunsaturated fatty acids from pharmaceutical-grade fish oil supplements results in pain reduction and functional improvement in patients with neuropathic pain.
-- https://www.practicalpainmanagement.com/treatments/nutraceutical/omega-3-fatty-acids-neuropathic-pain

Jump to this post

Replies to "@sita I should have mentioned that I took the list of supplements and shared them with..."
helennicola | @helennicola | Feb 23, 2021

Hi John, do you take all of the Protocol supplements? and fish oil plus hemp seed oil? and how much RAla do you take? I want to do a comparison as I do not do the Protocol but have always taken a lot on their list. Thanks, Helen

VIEW AND REPLY
ken82 | @ken82 | Feb 23, 2021

@johnbishop This from the NIH..
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828934/#:~:text=Harris%20cited%20extensive%20literature%20on,risk%20of%20aggressive%20prostate%20cancer.
Part of that study is as follows, "Harris cited extensive literature on fish intake and higher omega-3 fatty acid intake that demonstrated a lower incidence of prostate cancer incidence and death, better survival among men who already had prostate cancer, and a reduced risk of aggressive prostate cancer. Furthermore, citing World Foundation of Urology data,7 he noted that the incidence of prostate cancer is high in North America and Northern Europe (among Caucasians and African-Americans (63 and 102 per 100,000, respectively) but low in Asia. With the Japanese intake of omega-3 fatty acids at about eight-fold that of Americans and with their blood levels twice as high, one would expect a higher risk. However, the Japanese prostate cancer rate of 22.7 per 100,000 in 2008 was dramatically lower than the U.S. rates of 83.8 per 100,000.8"

VIEW AND REPLY